Vitamin D increases plasma renin activity independently of plasma Ca2+ via hypovolemia and β-adrenergic activity. - Wikidata - wikimedia - TriplyDB

Vitamin D increases plasma renin activity independently of plasma Ca2+ via hypovolemia and β-adrenergic activity.

Vitamin D increases plasma renin activity independently of plasma Ca2+ via hypovolemia and β-adrenergic activity.

http://www.wikidata.org/entity/Q37234733

about

Beneficial effects of calcitriol on hypertension, glucose intolerance, impairment of endothelium-dependent vascular relaxation, and visceral adiposity in fructose-fed hypertensive rats.Adrenal disorders: Is there Any role for vitamin D?

P2860

Q35182438-57265BE0-A833-4B36-84AC-C4DE70C12305 Q38985832-B0C8EE4E-F714-4D58-800A-B93365354A64

P2860

Vitamin D increases plasma renin activity independently of plasma Ca2+ via hypovolemia and β-adrenergic activity.

http://www.wikidata.org/entity/Q37234733

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Vitamin D increases plasma ren ...... mia and β-adrenergic activity.

@en

Vitamin D increases plasma ren ...... mia and β-adrenergic activity.

@nl

type

label

Vitamin D increases plasma ren ...... mia and β-adrenergic activity.

@en

Vitamin D increases plasma ren ...... mia and β-adrenergic activity.

@nl

prefLabel

Vitamin D increases plasma ren ...... mia and β-adrenergic activity.

@en

Vitamin D increases plasma ren ...... mia and β-adrenergic activity.

@nl

P1433

Q37234733-F67EDBF5-6CAD-4046-80E0-4202CBA44D45

P1476

Q37234733-F628F0C0-5875-44E8-94DA-728D947B2E47

P2093

Q37234733-15FCE73A-1633-4555-A135-3BA56DA32056

Q37234733-6CEECBC3-52C8-4161-B99F-6681ABF3F4B0

Q37234733-B1C89C2F-7718-4144-AE59-A2BE1E34B1A9

P2860

Q37234733-040D7292-6A55-4894-B550-FD239A2660EC

Q37234733-0B63A1DC-2D4E-48F9-8500-A338F97D3EEB

Q37234733-11FA02E1-F833-41CF-86DC-6B2E757AD273

Q37234733-18079E55-C344-4614-83D3-12E2C295343B

Q37234733-1CBFF5C4-7503-4C17-9BE1-0BF29BC74AAD

Q37234733-1D79117D-E72A-4ACC-9862-B24F5817A482

Q37234733-2044B12B-E467-478B-939A-AF2B0D598F6E

Q37234733-2486D0D7-D4A4-43F9-89E4-F1C2446FAABC

Q37234733-26C14EFA-D859-4463-BEE1-F14C084FAB6B

Q37234733-2973B5FC-BFD9-4432-8F47-C57DBF5016F8

P304

Q37234733-6427DE1D-1BE2-4F86-AD54-7EEA6A3192B9

P31

Q37234733-1C2E2ACF-198D-4038-A116-A68397E79A48

P356

Q37234733-17B4F831-266A-4327-BA1E-A280109F0829

P433

Q37234733-7592A717-6476-4080-A59E-0E8A8659E298

P478

Q37234733-BD8F4855-E8EF-4B60-AE4E-FB70DC6CE937

P577

Q37234733-470461A7-FB17-442D-B123-1B3D5A4A9DE4

P5875

Q37234733-EF2FBB8A-7335-4519-A8B1-EA044C567A63

P698

Q37234733-B42DB0C9-43DD-42DD-85A9-E9539E839CE8

P921

Q37234733-08747006-9365-460F-A9AA-DC65B8B6F937

Q37234733-e7210fff-2054-44d3-9dee-5dab52573dd8

P932

Q37234733-C4CD021D-DB5E-4A8B-80DD-8967E74BB67B

P356

AJPRENAL.00010.2013

P1433

American Journal of Physiology - Renal Physiology

P1476

Vitamin D increases plasma ren ...... mia and β-adrenergic activity.

@en

P2093

Douglas K Atchison

http://www.w3.org/2001/XMLSchema#string

Pamela Harding

http://www.w3.org/2001/XMLSchema#string

William H Beierwaltes

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism

Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome

Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning

Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid

Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats.

Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy

Acute activation of the calcium-sensing receptor inhibits plasma renin activity in vivo

Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.

P304

F1109-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.00010.2013

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

305

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255707340

http://www.w3.org/2001/XMLSchema#string

P698

23926179

http://www.w3.org/2001/XMLSchema#string

P921

P932

3798727

http://www.w3.org/2001/XMLSchema#string